Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
0.0000
Volume:- -
Turnover:- -
Market Cap:882.64M
PE:16.30
High:17.03
Open:17.03
Low:17.03
Close:17.03
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.86M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.27

Loading ...

Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook

TIPRANKS
·
Sep 29

Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance

MT Newswires Live
·
Sep 28

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

TIPRANKS
·
Sep 28

Zymeworks announces financial impact of Theravance Biopharma acquisition

TIPRANKS
·
Sep 28

Zymeworks Q2 FY26 Net Loss Widens to $45 Million; Revenue Guidance Rises to $278 Million-$292 Million for FY26

Reuters
·
Sep 28

Press Release: Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Dow Jones
·
Sep 28

Theravance Biopharma Completes Merger and Plans Nasdaq Delisting

TIPRANKS
·
Sep 24

Zymeworks Completes Acquisition of Theravance Biopharma

GlobeNewswire
·
Sep 24

Theravance Shareholders Approve Merger with Zymeworks Inc.

TIPRANKS
·
Sep 19

Theravance Biopharma Shareholders Held Extraordinary General Meeting on Merger Proposals

Reuters
·
Sep 19

Theravance Biopharma SVP Rhonda Farnum Sells Ordinary Shares Worth $226,773.25

Reuters
·
Sep 18

Theravance Biopharma issues disclosures amid Zymeworks merger

TIPRANKS
·
Sep 10

Theravance Biopharma Announces Shareholder Meeting on Merger Deal

Reuters
·
Sep 10

Theravance Biopharma details Phase 3 ampreloxetine data

TIPRANKS
·
Aug 26

Theravance Biopharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Metagenomi Q2 Net Loss Widens Cash Runway Seen Through 2027

Reuters
·
Aug 11

Rocket Pharmaceuticals Posts Q2 Profit Helped by PRV Sale

Reuters
·
Aug 11

Enanta Pharmaceuticals Q3 Revenue Misses Estimates, Hurt by Lower Royalties

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 Net Loss Widens on Higher Clinical Trial Spending

Reuters
·
Aug 11

Biohaven Q2 Net Loss Narrows on Lower R&D Spend

Reuters
·
Aug 11